{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:43:30Z","timestamp":1753922610343,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Familial hypocalciuric hypercalcemia (FHH, [OMIM #145980]) is recognized as a benign endocrine condition affecting PTH and calcium levels due to heterozygous inactivating mutations in the calcium sensing receptor (<jats:italic>CaSR<\/jats:italic>). The condition is often un- or misdiagnosed but may have a prevalence as high as 74 in 100.000. Here, the neonatal courses of two brothers with paternally inherited FHH (<jats:italic>CaSR<\/jats:italic>c.554G&amp;gt;A; p.(Arg185Gln)) are described. The older brother was born preterm at 25 weeks gestation with hypercalcemia and hyperparathyroidism. The younger brother, born full-term, had severe hyperparathyroidism, muscular hypotonia, thrombocytopenia, failure to thrive and multiple metaphyseal fractures. Treatment with cinacalcet was initiated, which resulted in subsequent reduction of PTH levels and prompt clinical improvement. While it is known that homozygous mutations in<jats:italic>CaSR<\/jats:italic>may lead to life-threatening forms of neonatal severe hyperparathyroidism (NSHPT), few reports have described a severe clinical course in neonates with FHH due to heterozygous mutations. However, based on the pathophysiological framework, in<jats:italic>de novo<\/jats:italic>or paternally transmitted FHH the differing calcium needs of mother and fetus can be expected to induce fetal hyperparathyroidism and may result in severe perinatal complications as described in this report. In summary, FHH is a mostly benign condition, but transient neonatal hyperparathyroidism may occur in affected neonates if the mutation is paternally inherited. If severe, the condition can be treated successfully with cinacalcet. Patients with FHH should be informed about the risk of neonatal disease manifestation in order to monitor pregnancies and neonates.<\/jats:p>","DOI":"10.3389\/fendo.2021.700612","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T17:32:36Z","timestamp":1633109556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Jakob","family":"H\u00f6ppner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Lais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Roll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Wegener-Panzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"H\u00f6gler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Grasemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The Calcium-Sensing Receptor in Physiology and in Calcitropic and Noncalcitropic Diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial Hypocalciuric Hypercalcemia and Related Disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res: Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000491038","article-title":"Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism","volume":"51","author":"Vannucci","year":"2018","journal-title":"Front Horm Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 Cause Familial Hypocalciuric Hypercalcemia Type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-Of-Function G\u03b111 Mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the Calcium-Sensing Receptor and Partner Proteins: Insights Into the Molecular Basis of Calcium Homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular Calcium Sensing and Extracellular Calcium","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial Hypocalciuric Hypercalcaemia: A Review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbm4.10362","article-title":"Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls","volume":"4","author":"Jones","year":"2020","journal-title":"JBMR Plus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2725486","article-title":"The Biochemical Profile of Familial Hypocalciuric Hypercalcemia and Primary Hyperparathyroidism During Pregnancy and Lactation: Two Case Reports and Review of the Literature","volume":"2016","author":"Ghaznavi","year":"2016","journal-title":"Case Rep Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz233","article-title":"Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene","volume":"105","author":"Marx","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000510623","article-title":"Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation","volume":"34899","author":"Gulcan-Kersin","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1306","article-title":"Neonatal Hyperparathyroidism With a Heterozygous Calcium-Sensing Receptor (CASR) R185Q Mutation: Clinical Benefit From Cinacalcet","volume":"96","author":"Reh","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198202043060502","article-title":"An Association Between Neonatal Severe Primary Hyperparathyreoidism and Familial Hypocalciuric Hypercalcemia in Three Kindreds","volume":"306","author":"Marx","year":"1982","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0388","article-title":"Clinical Lessons From the Calcium-Sensing Receptor","volume":"3","author":"Brown","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-008-0794-y","article-title":"Unusually Severe Phenotype of Neonatal Primary Hyperparathyroidism Due to a Heterozygous Inactivating Mutation in the CASR Gene","volume":"168","author":"Obermannova","year":"2009","journal-title":"Eur J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the Human Ca2+-Sensing Receptor Gene Cause Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118335","article-title":"Calcium-Sensing Receptor Mutations in Familial Benign Hypercalcemia and Neonatal Hyperparathyroidism","volume":"96","author":"Pearce","year":"1995","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.4.8636323","article-title":"Clustered Inactivating Mutations and Benign Polymorphisms of the Calcium Receptor Gene in Familial Benign Hypocalciuric Hypercalcemia Suggest Receptor Functional Domains","volume":"81","author":"Heath","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3209","article-title":"Neonatal Hyperparathyroidism and Pamidronate Therapy in an Extremely Premature Infant","volume":"120","author":"Fox","year":"2007","journal-title":"Pediatrics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0123","article-title":"Identification and Functional Characterization of a Novel Mutation in the Calcium-Sensing Receptor Gene in Familial Hypocalciuric Hypercalcemia: Modulation of Clinical Severity by Vitamin D Status","volume":"92","author":"Zajickova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.32.19537","article-title":"Expression and Characterization of Inactivating and Activating Mutations in the Human Ca2+(o)-Sensing Receptor","volume":"271","author":"Bai","year":"1996","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1172\/JCI119137","article-title":"In Vivo and In Vitro Characterization of Neonatal Hyperparathyroidism Resulting From a De Novo, Heterozygous Mutation in the Ca2+-Sensing Receptor Gene: Normal Maternal Calcium Homeostasis as a Cause of Secondary Hyperparathyroidism in Familial Benign Hyp","volume":"99","author":"Bai","year":"1997","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2018-0307","article-title":"Cinacalcet Therapy in an Infant With an R185Q Calcium-Sensing Receptor Mutation Causing Hyperparathyroidism: A Case Report and Review of the Literature","volume":"32","author":"Forman","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0223","article-title":"Heterozygous Inactivating CaSR Mutations Causing Neonatal Hyperparathyroidism: Function, Inheritance and Phenotype","volume":"175","author":"Glaudo","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B26","first-page":"P16","article-title":"Familial Hypocalciuric Hypercalcaemia and Pregnancy Outcome","volume":"19","author":"Murthy","year":"2009","journal-title":"Endocr Abstr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-004-1491-0","article-title":"Neonatal Severe Hyperparathyroidism: Genotype\/phenotype Correlation and the Use of Pamidronate as Rescue Therapy","volume":"163","author":"Waller","year":"2004","journal-title":"Eur J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1687-9856-2012-13","article-title":"A Novel CaSR Mutation Presenting as a Severe Case of Neonatal Familial Hypocalciuric Hypercalcemia","volume":"2012","author":"Tonyushkina","year":"2012","journal-title":"Int J Pediatr Endocrinol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.83.1.53","article-title":"Neonatal Hyperparathyroidism: The Natural Course in the Absence of Surgical Intervention","volume":"83","author":"Harris","year":"1989","journal-title":"Pediatrics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/003655100750044875","article-title":"Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism Associated With Mutations in the Human Ca2+-Sensing Receptor Gene in Three Danish Families","volume":"60","author":"Schwarz","year":"2000","journal-title":"Scand J Clin Lab Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01387-2","article-title":"Maternal and Fetal Vitamin D and Their Roles in Mineral Homeostasis and Fetal Bone Development","volume":"44","author":"Ryan","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/fn.86.2.F82","article-title":"Skeletal Development in Premature Infants: A Review of Bone Physiology Beyond Nutritional Aspects","volume":"86","author":"Rauch","year":"2002","journal-title":"Arch Dis Child: Fetal Neonatal Ed"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population","volume":"106","author":"Dershem","year":"2020","journal-title":"Am J Hum Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed Population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/adc.69.3_Spec_No.319","article-title":"Self Limiting Neonatal Primary Hyperparathyroidism Associated With Familial Hypocalciuric Hypercalcaemia","volume":"69","author":"Wilkinson","year":"1993","journal-title":"Arch Dis Child"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01874.x","article-title":"The Role of Calcimimetics in the Treatment of Hyperparathyroidism","volume":"37","author":"W\u00fcthrich","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01684.x","article-title":"Normalization of Serum Calcium by Cinacalcet in a Patient With Hypercalcaemia Due to a De Novo Inactivating Mutation of the Calcium-Sensing Receptor","volume":"260","author":"Timmers","year":"2006","journal-title":"J Internal Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03027.x","article-title":"Correction of Hypercalcaemia by Cinacalcet in Familial Hypocalciuric Hypercalcaemia","volume":"68","author":"Festen-Spanjer","year":"2007","journal-title":"Clin Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1028","article-title":"Gain and Loss of Function Mutations of the Calcium-Sensing Receptor and Associated Proteins: Current Treatment Concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.700612\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T23:40:03Z","timestamp":1673394003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.700612\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":39,"alternative-id":["10.3389\/fendo.2021.700612"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.700612","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"700612"}}